US2017119686A1PendingUtilityA1

Methods for the production, modification and use of metallic nanoparticles

42
Assignee: UNIV LOMA LINDAPriority: Feb 28, 2012Filed: Jun 10, 2016Published: May 4, 2017
Est. expiryFeb 28, 2032(~5.6 yrs left)· nominal 20-yr term from priority
B01J 13/22A61K 33/38B82Y 5/00A61K 47/6929A61K 47/60A61K 33/26A61K 47/6923A61K 33/30A61K 33/245A61K 9/5192A61K 33/34A61K 9/14A61K 9/513A61K 33/24A61K 33/242
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein is a method for producing triblock copolymer-coated metallic nanoparticle seeds which increases the size and shape homogeneity of the triblock copolymer-coated metallic nanoparticle seeds. Also provided is a quantity of triblock copolymer-coated metallic nanoparticle seeds. Also provided herein is a method for producing triblock copolymer-coated metallic nanoparticles which increases the size and shape homogeneity of the triblock copolymer-coated metallic nanoparticles. Also provided is a quantity of triblock copolymer-coated metallic nanoparticles. Further provided herein is a method for producing modified metallic nanoparticles which increases the size and shape homogeneity of the modified metallic nanoparticles. Also provided is a quantity of modified metallic nanoparticles.

Claims

exact text as granted — not AI-modified
1 - 221 . (canceled) 
     
     
         222 . A pharmaceutical suitable for treating a patient with a condition or disease, the pharmaceutical comprising triblock copolymer-coated metallic nanoparticles, wherein the triblock copolymer-coated metallic nanoparticles have a median maximum particle diameter size standard deviation of ±25% of the median maximum particle diameter size by electron microscopy. 
     
     
         223 . The pharmaceutical of  claim 222 , further comprising one or more than one substance selected from the group consisting of a binder, a coloring chemical and a flavoring chemical. 
     
     
         224 . A pharmaceutical suitable for treating a patient with a condition or disease, the pharmaceutical comprising modified metallic nanoparticles, wherein the modified metallic nanoparticles have a median maximum particle diameter size standard deviation of ±25% of the median maximum particle diameter size by electron microscopy. 
     
     
         225 . The pharmaceutical of  claim 224 , further comprising one or more than one substance selected from the group consisting of a binder, a coloring chemical and a flavoring chemical.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.